Biohaven Pharma (BHVN) Tops Q3 EPS by 24c
Biohaven Pharma (NYSE: BHVN) reported Q3 EPS of ($1.64), $0.24 better than the analyst estimate of ($1.88).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.
Biohaven Pharma (NYSE: BHVN) reported Q3 EPS of ($1.64), $0.24 better than the analyst estimate of ($1.88).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.